FDA Declines to Approve Jazz Fibromyalgia Drug
Jazz Pharmaceuticals Inc released information stating that the US Food and Drug Administration (FDA) has sent the company a complete response letter (CRL) regarding the company’s New Drug Application (NDA) for JZP-6 (sodium oxybate) for the tre
Read More